Search Results - "Nghiem, Van T"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Health-related risk behaviors among U.S. childhood cancer survivors: a nationwide estimate by Nghiem, Van T, Jin, Jing, Mennemeyer, Stephen T, Wong, F Lennie

    Published in BMC cancer (06-02-2024)
    “…Childhood cancer survivors (CCS) are subject to a substantial burden of treatment-related morbidity. Engaging in health protective behaviors and eliminating…”
    Get full text
    Journal Article
  2. 2

    Disparities in cervical cancer survival among Asian-American women by Nghiem, Van T., MSPH, Davies, Kalatu R., PhD, Chan, Wenyaw, PhD, Mulla, Zuber D., PhD, Cantor, Scott B., PhD

    Published in Annals of epidemiology (01-01-2016)
    “…Abstract Purpose We compared overall survival and influencing factors between Asian-American women as a whole and by subgroup with white women with cervical…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Preliminary study on HIV status disclosure to perinatal infected children: retrospective analysis of administrative records from a pediatric HIV clinic in the southern United States by Budhwani, Henna, Mills, Lori, Marefka, Lauren E B, Eady, Sequoya, Nghiem, Van T, Simpson, Tina

    Published in BMC research notes (24-05-2020)
    “…The World Health Organization recommends disclosing HIV-status between 6 and 12 years; American Academy of Pediatrics recommends that children are informed at…”
    Get full text
    Journal Article
  5. 5

    Prevalence and correlates of HIV infection among men who inject drugs in a remote area of Vietnam by Nghiem, Van T, Bui, Thanh C, Nadol, Patrick P, Phan, Son H, Kieu, Binh T, Kling, Ryan, Hammett, Theodore M

    Published in Harm reduction journal (14-02-2018)
    “…Lack of information on the HIV epidemic among men who inject drugs (MWID) in northwestern Vietnam, a remote area, may hamper national efforts to control the…”
    Get full text
    Journal Article
  6. 6

    Cost-Effectiveness of Competing Treatment Strategies for Clostridium difficile Infection: A Systematic Review by Le, Phuc, Nghiem, Van T, Mullen, Patricia Dolan, Deshpande, Abhishek

    “…BACKGROUND Clostridium difficile infection (CDI) presents a substantial economic burden and is associated with significant morbidity. While multiple treatment…”
    Get full text
    Journal Article
  7. 7

    Healthcare utilization and cost barriers among U.S. childhood cancer survivors by Nghiem, Van T., Alanaeme, Chibuike J., Mennemeyer, Stephen T., Wong, F. Lennie

    Published in Pediatric blood & cancer (01-08-2023)
    “…Background To evaluate healthcare utilization and cost barrier patterns among childhood cancer survivors (CCS) compared with noncancer controls. Procedure…”
    Get full text
    Journal Article
  8. 8

    Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review by Chiyaka, Edward T., Nghiem, Van T., Zhang, Lu, Deshpande, Abhishek, Mullen, Patricia Dolan, Le, Phuc

    Published in PharmacoEconomics (13-02-2019)
    “…Background Herpes zoster (HZ) is one of the most common diseases among adults. Its reactivation is characterized by a severe and painful complication. In…”
    Get full text
    Journal Article
  9. 9

    Patterns of Scientific and Clinical Impact in Cancer Randomized Clinical Trials by Nghiem, Van T, Vaidya, Riha, Unger, Joseph M

    Published in JAMA network open (01-06-2022)
    “…This cohort study examines whether randomized clinical trials of cancer treatment with negative findings that inform cancer care guidelines are recognized for…”
    Get full text
    Journal Article
  10. 10

    Community-Level Social Determinants of Health and Well-Child Visits Among Alabama Medicaid Enrollees by Brisendine, Anne E, Sharma, Pradeep, Liu, Ye, McDougal, Julie, Becker, David, Nghiem, Van T, Sen, Bisakha

    Published in Population health management (01-04-2022)
    “…Well-child visits focus on health promotion and disease detection and are critical to the appropriate provision of care. Evidence has shown that participation…”
    Get more information
    Journal Article
  11. 11

    Economic Evaluations in National Cancer Institute–Sponsored Network Cancer Clinical Trials by Nghiem, Van T., Vaidya, Riha, Lyman, Gary H., Hershman, Dawn L., Ramsey, Scott D., Unger, Joseph M.

    Published in Value in health (01-12-2020)
    “…Amid a rapid increase in cancer care costs, we examined the extent to which economic evaluations (EEs) were conducted for new treatments evaluated in clinical…”
    Get full text
    Journal Article
  12. 12

    Overtreatment and Cost-Effectiveness of the See-and-Treat Strategy for Managing Cervical Precancer by Nghiem, Van T, Davies, Kalatu R, Beck, J Robert, Follen, Michele, Cantor, Scott B

    “…See-and-treat using loop electrosurgical excision procedure (LEEP) has been recommended as an alternative in managing high-grade cervical squamous…”
    Get full text
    Journal Article
  13. 13

    Association of National Cancer Institute-Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications by Unger, Joseph M, Nghiem, Van T, Hershman, Dawn L, Vaidya, Riha, LeBlanc, Michael, Blanke, Charles D

    Published in JAMA network open (04-09-2019)
    “…National Cancer Institute Clinical Trial Network (NCTN) groups serve a vital role in identifying effective new antineoplastic regimens. However, the downstream…”
    Get full text
    Journal Article
  14. 14

    Post-GAVI sustainability of the Haemophilus influenzae type b vaccine program: The potential role of economic evaluation by Le, Phuc, Nghiem, Van T., Swint, J. Michael

    Published in Human vaccines & immunotherapeutics (01-09-2016)
    “…Haemophilus influenzae type b (Hib) can cause severe invasive diseases which are, however, preventable by vaccination. To increase access to Hib vaccine, GAVI…”
    Get full text
    Journal Article
  15. 15
  16. 16

    The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials by Unger, Joseph M., Barlow, William E., Tangen, Catherine M., Ramsey, Scott D., Thompson, Ian M., Klein, Eric A., LeBlanc, Michael, Blanke, Charles D., Goodman, Phyllis J., Minasian, Lori M., Nghiem, Van T., Hershman, Dawn L.

    Published in Cancer epidemiology (01-08-2018)
    “…[Display omitted] •U.S. federal funding agencies rarely invest in large chemoprevention trials.•We examined whether cancer chemoprevention trials have strong…”
    Get full text
    Journal Article
  17. 17

    The impact of NCI-sponsored network group clinical trials on guideline care and new drug indications by Unger, Joseph M., Nghiem, Van T., Hershman, Dawn L., Vaidya, Riha, LeBlanc, Michael Leo, Blanke, Charles David

    Published in Journal of clinical oncology (20-05-2019)
    “…Abstract only 6604 Background: National Cancer Institute Clinical Trial Network (NCTN) groups serve a vital role in identifying new antineoplastic regimens…”
    Get full text
    Journal Article
  18. 18
  19. 19

    What should accountable care organizations learn from the failure of health maintenance organizations? A theory based systematic review of the literature by Amir Alishahi Tabriz, Elham Nouri, Huyen T Vu, Van T. Nghiem, Brandt Bettilyon, Pooriya Gholamhoseyni, Nazanin Kiapour

    Published in Social determinants of health (01-01-2017)
    “…Background: Health Maintenance Organization (HMO), were once viewed as the most cost-effective model for achieving such efficient high-quality health care. A…”
    Get full text
    Journal Article